カテゴリ： MarketLine, フランス, 企業調査

Sanofi SA：戦略・SWOT・企業財務分析

◆英語タイトル：Sanofi SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015203
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Sanofi SA – Strategy, SWOT and Corporate Finance Report
Summary

Sanofi SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanofi (or ‘the group’) is a France-based international pharmaceutical group engaged in research, development, manufacture and marketing of healthcare products. It offers pharmaceuticals, human vaccines and animal and consumer health products. The group operates in about 100 countries. It is headquartered in Paris, France, and employed 113,496 people as on December 31, 2014.

Scope

- Detailed information on Sanofi SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi SA including a breakdown and examination of key business segments
- Intelligence on Sanofi SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanofi SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Sanofi SA: Company Overview
Sanofi SA: Overview and Key Facts
Sanofi SA: Overview
Sanofi SA: Key Facts
Sanofi SA: Key Employees
Sanofi SA: Key Employee Biographies
Sanofi SA: Major Products and Services
Sanofi SA: Company History
Sanofi SA: Management Statement
Sanofi SA: Locations and Subsidiaries
Sanofi SA: Key Competitors
Sanofi SA: Company Analysis
Sanofi SA: Business Description
Sanofi SA: SWOT Analysis
Sanofi SA: SWOT Overview
Sanofi SA: Strengths
Sanofi SA: Weaknesses
Sanofi SA: Opportunities
Sanofi SA: Threats
Sanofi SA: Corporate Financial Deals Activity
Sanofi SA: Financial Deals Overview
Sanofi SA: Targets and Partners
Sanofi SA: Top Deals 2013 – 2017YTD*
Sanofi SA: Mergers and Acquisitions
Sanofi SA: Corporate Venturing
Sanofi SA: Partnership
Sanofi SA: Divestments
Sanofi SA: Recent Developments
Sanofi SA: News and Events Summary
Sanofi SA: Business Expansion
Sanofi SA: Contracts
Sanofi SA: Corporate Governance
Sanofi SA: Financial Performance
Sanofi SA: Market Developments
Sanofi SA: Regulatory and Legal Events
Sanofi SA: Research & Development
Sanofi SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Sanofi SA: Key Facts
Table 2: Sanofi SA: Key Employees
Table 3: Sanofi SA: Locations and Subsidiaries
Table 4: Sanofi SA: Key Competitors
Table 5: Sanofi SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sanofi SA: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Sanofi SA: M&A Average Deal Size - Value (US$m)
Table 8: Sanofi SA: Targets and Partners
Table 9: Sanofi SA: Top Deals 2013 - 2017YTD*
Table 10: Sanofi SA: M&A Volume and Value Trend (2013 - YTD*2017)
Table 11: Sanofi SA: M&A Activity by Geography (2013 - YTD*2017)
Table 12: Sanofi SA: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 13: Sanofi SA: Corporate Venturing by Geography (2013 - YTD*2017)
Table 14: Sanofi SA: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 15: Sanofi SA: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 16: Sanofi SA: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 17: Sanofi SA: Divestments by Geography (2013 - YTD*2017)
Table 18: Sanofi SA: News and Events Summary
Table 19: Sanofi SA: Business Expansion
Table 20: Sanofi SA: Contracts
Table 21: Sanofi SA: Corporate Governance
Table 22: Sanofi SA: Financial Performance
Table 23: Sanofi SA: Market Developments
Table 24: Sanofi SA: Regulatory and Legal Events
Table 25: Sanofi SA: Research & Development
Table 26: Sanofi SA: Strategy and Operations

★海外企業調査レポート[Sanofi SA：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Emzor Pharmaceutical Industries Ltd：企業の戦略的SWOT分析
    Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • SPI Energy Co Ltd：電力：M&Aディール及び事業提携情報
    Summary Spi Energy Co Ltd (Spi Energy), formerly Solar Power Inc, is a photovoltaic (PV) solutions provider. The company offers development, financing, installation, operation and sale of utility-scale and residential solar power projects. It also operates online energy e-commerce and investment pla …
  • Alfa Group Consortium：企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Venture Global LNG Inc：石油・ガス：M&Aディール及び事業提携情報
    Summary Venture Global LNG Inc (VGLI) is an exporter of american-produced liquefied natural gas. The company owns and manages two Louisiana-based export projects Calcasieu Pass and Plaquemines. The company through subsidiary Venture Global Calcasieu Pass, LLC, operates Calcasieu Pass project, which …
  • Alitalia – Societa Aerea Italiana S.p.A.：戦略・SWOT・企業財務分析
    Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Alitalia - Societa Aerea Italiana S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Eagle Pharmaceuticals Inc (EGRX)：企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • SurgaColl Technologies Ltd：医療機器：M&Aディール及び事業提携情報
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops novel tissue regeneration products for the surgical treatment of disease of the bone, cartilage and other human tissue. The company’s products include hydroxycoll and chondrocoll. Its hydroxycoll is …
  • New Zealand Energy Corp (NZ)：企業の財務・戦略的SWOT分析
    Summary New Zealand Energy Corp (New Zealand Energy), formerly East Coast Energy Ventures Ltd is an oil and gas company. The company carries out the business of production, development and exploration of conventional and unconventional oil and natural gas prospects in New Zealand. It acquires strate …
  • Caleres Inc (CAL)：企業の財務・戦略的SWOT分析
    Caleres Inc (CAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Wright Medical Group NV (WMGI)：医療機器：M&Aディール及び事業提携情報
    Summary Wright Medical Group NV (Wright) is a medical device company which focuses on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and hand; foot and ankle products. It a …
  • SARIA AS GmbH & Co KG：企業の戦略的SWOT分析
    SARIA AS GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • The Jones Financial Companies, L.L.L.P.：企業の戦略的SWOT分析
    The Jones Financial Companies, L.L.L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Vericel Corp (VCEL)-医療機器分野：企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • Fanuc Corp (6954)：企業の財務・戦略的SWOT分析
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Silver Fern Farms Limited：企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • One Call Care Management Inc：医療機器：M&Aディール及び事業提携情報
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc, is a healthcare technology provider that provides specialized cost containment services. The company offers diagnostics, dental, transport, complex home care, equipment and physical therapy, among others. It provides value a …
  • Rural Areas Electricity Company SAO.C.：発電所・企業SWOT分析
    Rural Areas Electricity Company SAO.C. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Crownhaitai Holdings Co Ltd：企業の戦略・SWOT・財務分析
    Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • University of Texas Southwestern Medical Center-医療機器分野：企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • Nichi-Iko Pharmaceutical Co Ltd (4541)：企業の財務・戦略的SWOT分析
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahis …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆